CEU Courses

The process of obtaining and being successful with a cochlear implant is a complex process. This course, using real case studies, details the nature, components, and communication of successful cochlear implant care by an interdisciplinary team.

This two-part series explores the current state of teleaudiology today, from practice to legislation. Part 2 provides an overview of the law and the landscape surrounding teleaudiology and guidance for navigating the future.

This course will provide an in-depth review of Unitron TrueFit fitting software, review what’s new in Unitron TrueFit v5.4, highlight Unitron’s signature features, and review Experience Innovations. Finally, to support continuous patient success, we will review troubleshooting tips and tricks specific to Unitron products and features.

This course will discuss the evolution of the My Starkey app in providing even greater benefit, flexibility, and ease of use for the Genesis AI hearing aid wearer.

Starkey is at the forefront of innovation, continuing to push the edge of what is possible. If you have ever wondered how hearing technology is developed, Dr. Dave Fabry and Nate Johnson, Starkey’s Director of Product Management, have a detailed discussion on how key decisions are made, how critical feedback from both hearing care professionals and patients is incorporated into product development, and the complexity of hearing aid development cycles. Dave and Nate have a candid discussion on how by transforming hearing aids from single function listening enhancement devices into multi-functional and multipurpose health and communication tools with advanced sensors and artificial intelligence technologies, today’s hearing aids have sophisticated and groundbreaking technology that is having a real impact on people’s lives. Learn more about the addition of new products to the impressive Genesis AI product line, as well as new enhancements designed to offer unprecedented benefits to both patients and hearing healthcare professionals.

In this special episode, Dr. Dave Fabry and Dr. Jamie Hand untangle the intricate findings of the long-awaited ACHIEVE Study that just dropped last week. It revealed a startling 48% reduction in cognitive decline among a specific group, shedding light on the power of intervention. We were excited to discuss how this vital data can be used to empower and educate patients about comorbidities linked to untreated hearing loss.

We continue to put Genesis AI to the test. In this episode, you’ll hear directly from hearing professionals who have tried it, fit it, and are out in the field right now offering it to their patients. From sound quality and battery life to Pro Fit for hearing professionals, more than two dozen people share their reactions to our all-new hearing technology. Have you tried Genesis AI yet? We’d love to hear from you!

June marks the longest day of the year. For the Alzheimer’s Association, The Longest Day is an important day of awareness and fundraising. In this episode, Dave sits down with Dr. Heather Snyder, Vice President of Medical and Scientific Affairs at the Alzheimer’s Association, to discuss the ongoing research into the connection between hearing loss and dementia. One of the latest studies, which found that treating hearing loss could mean reducing the risk of dementia, was released in The Lancet this spring. Dr. Snyder also talks about the early warning signs of Alzheimer’s Disease, and why it’s important for hearing healthcare providers to be aware of them.

Take a deep dive into the research and development behind Starkey’s waterproof Genesis AI hearing aids. In this episode, Dave chats with Brian Dahl, Starkey’s Vice President of Quality and Regulatory about the rigorous testing that went into these devices and why moisture is such a big deal for hearing aid wearers.

This two-part series explores the current state of teleaudiology today, from practice to legislation. Part 1 provides an overview of teleaudiology clinical provision including implementation and challenges using real-world examples.